Methods | Multicentre, randomised controlled trial without the use of a placebo conducted in 5 NICUs in Belgium (2 hospitals in Antwerp, 1 hospital each in Ghent, Bruges, and Rocourt) Study period: not stated Blinding of randomisation ‐ yes Blinding of intervention ‐ no Complete follow‐up ‐ yes Blinding of outcome measurement(s) ‐ no |
|
Participants | 148 infants with PMA 24 to 32 weeks, who had RDS and ECHO‐confirmed PDA were randomised Ibuprofen: 74 infants, mean (SD) GA 29.0 (2.3) weeks; BW 1230 (390) grams; surfactant treatment 56 Indomethacin: 74 infants, mean (SD) GA 29.0 (2.1) weeks; BW 1230 (380) grams; surfactant treatment 63 |
|
Interventions | Ibuprofen: IV 10 mg/kg as the initial dose, followed at 24‐hour intervals by 2 doses of 5 mg/kg Indomethacin: IV 0.2 mg/kg every 12 hours |
|
Outcomes | PDA closure rate, oliguria, PDA ligation rate, mortality by 30 days, NEC, localised bowel perforation, sepsis, PVL, CLD at 28 days, time to regain BW, time to full enteral feeding | |
Notes | We believe this study has been reported in abstract form when 103 preterm infants were enrolled (Van Overmeire 1998), but we have not been able to verify this with the authors. No information on funding provided | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | No information provided |
Allocation concealment (selection bias) | Low risk | Sealed opaque envelopes were used |
Blinding of participants and personnel (performance bias) All outcomes | High risk | Ibuprofen and indomethacin were given at different times |
Blinding of outcome assessment (detection bias) All outcomes | Low risk | ECHOs were performed by physicians who were unaware of the infants' treatment assignments |
Incomplete outcome data (attrition bias) All outcomes | Low risk | Outcomes reported for all randomised infants |
Selective reporting (reporting bias) | Unclear risk | Study protocol was not available to us so we could not ascertain if there were deviations from the protocol |
Other bias | Low risk | Appeared free of other bias |